The safety of allergenic immunotherapy

The Journal of Allergy and Clinical Immunology

Volumn 85, Issue 2, 1990, Pages 522-525

  Norman, Philip S ^a   Van Metre Jr , Thomas E ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; ANAPHYLAXIS; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; SAFETY; SHORT SURVEY;

ALLERGENS; ANAPHYLAXIS; HUMAN; IMMUNOTHERAPY; RISK FACTORS; SKIN TESTS; TIME FACTORS;

EID: 0025157649     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(90)90165-Z     Document Type: Article

References (15)

1. Prophylactic inoculation against hay fever
2. The risk of inducing constitutional reactions in allergic patients
3. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy
4. Desensitizing vaccines
5. Position Statement Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts
6. Onset of polyarteritis nodosa during allergic hyposensitization treatment
7. Case 26-1980: pemphigus vulgaris after hyposensitization injections [Letter]
8. Serum sickness triggered by anaphylaxis: a complication of immunotherapy
9. Brachial plexus neuropathy
10. Immune complex-mediated disease not a factor in patients on maintenance venom immunotherapy
11. Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade
12. Military antishock trousers in a patient with adrenergic-resistant anaphylaxis
13. A ten-year review of adverse reactions to immunotherapy [Abstract]
14. Fatalities from immunotherapy (IT) and skin testing (ST)
15. Current status of allergen immunotherapy